Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract P72: Pattern of Deactivation of Implantable Cardioverter Defibrillator in Inpatient Hospice Units

View through CrossRef
Background: There have been an increasing number of patients receiving implantable cardioverter defibrillators (ICDs) over the last decade. Although ICDs prevent arrhythmic death, patients may still develop other terminal illnesses, or progression of underlying heart failure. ICD- delivered shocks are associated with significant pain, anxiety and reduced quality of life. Therefore for this population of patients, it may become undesirable to receive shock therapy nearing the end of life. We reviewed the practices for ICD deactivation on a series of patients admitted to a hospice center. We hypothesized that for patients with ICDs, the frequency for ICD deactivation at end of life would be low. Methods: In this retrospective study we reviewed records of patients with ICDs who were admitted to the Hildebrandt Hospice Care Center, an inpatient hospice facility, in Rochester NY from January 2005 to December 2009. Information regarding patient's demographics, indications for ICD implantation, deactivation of ICD (frequency, location) and history of shock in hospice care was recorded. Results: We identified 32 patients who were admitted to inpatient hospice with ICDs for primary prevention of sudden cardiac arrest. The mean age was 78 + 9 years and 23 out of 32 (72%) were male. Sixteen patients had metastatic cancer, 8 patients had sepsis, 4 patients had stroke, 3 patients had renal disease and one patient had liver disease. Twenty (62%) patients had their ICD deactivated in the hospital before transferring to inpatient hospice. Nine (28%) patients were transferred to the center without ICD deactivation. Among these patients, 3 (10%) received ICD shock while in hospice and subsequently died in the center (average 2 days after receiving the shock). Three (10%) patients refused to have their ICD deactivated. Out of these three patients, two died in the hospice center while one patient was discharged home and none of them had ICD shock during hospice admission. Conclusion: The discussion about ICD deactivation should be initiated in terminally ill patients who are opting for hospice care for end of life care. Deactivating the device allows patients to die without the discomfort of electric shocks.
Title: Abstract P72: Pattern of Deactivation of Implantable Cardioverter Defibrillator in Inpatient Hospice Units
Description:
Background: There have been an increasing number of patients receiving implantable cardioverter defibrillators (ICDs) over the last decade.
Although ICDs prevent arrhythmic death, patients may still develop other terminal illnesses, or progression of underlying heart failure.
ICD- delivered shocks are associated with significant pain, anxiety and reduced quality of life.
Therefore for this population of patients, it may become undesirable to receive shock therapy nearing the end of life.
We reviewed the practices for ICD deactivation on a series of patients admitted to a hospice center.
We hypothesized that for patients with ICDs, the frequency for ICD deactivation at end of life would be low.
Methods: In this retrospective study we reviewed records of patients with ICDs who were admitted to the Hildebrandt Hospice Care Center, an inpatient hospice facility, in Rochester NY from January 2005 to December 2009.
Information regarding patient's demographics, indications for ICD implantation, deactivation of ICD (frequency, location) and history of shock in hospice care was recorded.
Results: We identified 32 patients who were admitted to inpatient hospice with ICDs for primary prevention of sudden cardiac arrest.
The mean age was 78 + 9 years and 23 out of 32 (72%) were male.
Sixteen patients had metastatic cancer, 8 patients had sepsis, 4 patients had stroke, 3 patients had renal disease and one patient had liver disease.
Twenty (62%) patients had their ICD deactivated in the hospital before transferring to inpatient hospice.
Nine (28%) patients were transferred to the center without ICD deactivation.
Among these patients, 3 (10%) received ICD shock while in hospice and subsequently died in the center (average 2 days after receiving the shock).
Three (10%) patients refused to have their ICD deactivated.
Out of these three patients, two died in the hospice center while one patient was discharged home and none of them had ICD shock during hospice admission.
Conclusion: The discussion about ICD deactivation should be initiated in terminally ill patients who are opting for hospice care for end of life care.
Deactivating the device allows patients to die without the discomfort of electric shocks.

Related Results

The effects of age on quality of life in implantable cardioverter defibrillator recipients
The effects of age on quality of life in implantable cardioverter defibrillator recipients
Background.  The implantable cardioverter defibrillator shows superiority over conventional pharmacological therapy. The implantable cardioverter defibrillator has been implanted w...
Hospice preference among families with cancer patients in China: An exploratory study
Hospice preference among families with cancer patients in China: An exploratory study
Abstract Background: The reasons for hospice underuse in China needs exploration from the perspective of patients with cancer and their families. Furthermore, existing lite...
Identification of Linear Epitopes in the C-Terminal Region of ASFV p72 Protein
Identification of Linear Epitopes in the C-Terminal Region of ASFV p72 Protein
African swine fever, which is induced by the African swine fever virus (ASFV), poses a significant threat to the global pig industry due to its high lethality in domestic pigs and ...
Hispanics and Hospice Care: A Systematic Review
Hispanics and Hospice Care: A Systematic Review
Abstract Hospice care has demonstrated improved pain and symptom relief for patients at end-of-life, however, Hispanics have significantly lower rates of hospice use...
Structural Design and Assessing of Recombinantly Expressed African Swine Fever Virus p72 Trimer in Saccharomyces cerevisiae
Structural Design and Assessing of Recombinantly Expressed African Swine Fever Virus p72 Trimer in Saccharomyces cerevisiae
In an effort to control the outbreak of the African Swine Fever Virus (ASFV), there is an urgent need to develop an effective method to prevent the pandemic, including vaccines and...
Protein-tyrosine Kinase p72 syk Is Activated by Platelet Activating Factor in Platelets
Protein-tyrosine Kinase p72 syk Is Activated by Platelet Activating Factor in Platelets
SummaryIt has been demonstrated that activation of platelets by platelet-activating factor (PAF) results in a dramatic increase in tyrosine phosphorylation of several cellular prot...

Back to Top